Research Use Only. KIRhub outputs are computational research artifacts. They are not validated for clinical decision-making, diagnosis, or treatment.
KIRhub 2.0· v2
Ependymoma Hub
V1V2
Sign in
← Cases

TSSK4

RBC: TSSK4 · Substrate: RS Peptide Long + Mn ·

Top inhibitors

MeasuredDerived
DrugInhibition %Gini
Capivasertib9.30.64
Remibrutinib4.50.72
Canertinib1.50.67
Darovasertib0.00.72
Inavolisib0.00.68
Quizartinib0.00.74
Repotrectinib0.00.61

Known variants

No variants catalogued.
Open in new tab